The Technical AnalystExchange: HKSE Sector: Life Sciences Tools & Services Industry: Medical Care Facilities
China Health Group Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
20.00% HKD0.132
America/New_York / 3 mai 2024 @ 02:45
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 131.39 mill |
| EPS: | -0.0600 |
| P/E: | -2.20 |
| Earnings Date: | Mar 27, 2024 |
| SharesOutstanding: | 995.35 mill |
| Avg Daily Volume: | 0.0554 mill |
| RATING 2024-05-03 |
|---|
| C- |
| Strong Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Sell | |
| P/E: | Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | n/a | n/a | n/a | |||
| Debt | n/a | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -2.20 | sector: PE 19.17 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.04x |
| Company: PE -2.20 | industry: PE 53.97 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
HKD-0.0377 (-128.54%) HKD-0.170 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
HKD 0.129 - 0.135 ( +/- 2.27%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | HKD0.132 (20.00% ) |
| Volume | 0.620 mill |
| Avg. Vol. | 0.0554 mill |
| % of Avg. Vol | 1 118.95 % |
| Signal 1: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 8225.HK
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
8225.HK
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.